Transition Therapeutics Inc.
) was a big mover last session with shares rising nearly 8% on the
day. The move came on solid volume too with far more shares
changing hands than in a normal session. This breaks the recent
trend for the company, as the stock is now trading above the past
one month's volatile price range of $6.02 to $6.77.
This biopharmaceutical company has not seen any estimate revision
over the last 30 days. The Zacks Consensus Estimate also remained
unchanged over the same period.Friday's rally is encouraging
though, so make sure to keep a close watch on this stock in the
Transition Therapeutics currently holds a Zacks Rank #3 (Hold)
Better-ranked stocks in the biomedical industry include
Alexion Pharmaceuticals, Inc.
Biogen Idec Inc.
). While Alexion sports a Zacks Rank #1 (Strong Buy), Biogen Idec
and Actelion carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
ACTELION LTD (ALIOF): Get Free Report
ALEXION PHARMA (ALXN): Free Stock Analysis
BIOGEN IDEC INC (BIIB): Free Stock Analysis
TRANSITN THERAP (TTHI): Get Free Report
To read this article on Zacks.com click here.